Miguel Valderrábano, MD, FACC

Lois and Carl Davis Centennial Chair, DeBakey Heart & Vascular Center
Professor of Cardiology, Institute for Academic Medicine
Associate Member, Research Institute
Houston Methodist
Weill Cornell Medical College

Research Lab


Dr. Valderrábano came to Houston from Los Angeles where he was director of the Implanted Devices Clinic at the UCLA Cardiac Arrhythmia Center and assistant professor of medicine at UCLA Medical Center.

Dr. Valderrábano received his medical degree from Universidad Autónoma de Madrid (UAM) School of Medicine in Madrid, Spain, and internal medicine training at UCLA. He completed his cardiology and electrophysiology training at Cedars-Sinai Medical Center in Los Angeles, where he was chief cardiology fellow. He then joined the faculty at the David Geffen School of Medicine at UCLA.

Description of Research

Dr. Valderrábano’s research and clinical interests focus on finding new and more effective treatments for atrial fibrillation, including epicardial mapping and ablation. His research has been funded by grants from the American Heart Association and the National Institutes of Health (NIH).

Areas Of Expertise

Atrial fibrillation Epicardial mapping Ablation
Education & Training

Research Fellowship, Cedar-Sinai Medical Center and UCLA SCOR Group
Clinical Fellowship, Cedars-Sinai Medical Center
Internship, UCLA - West Los Angeles VA Medical Center
MD, Universidad Autonoma de Madrid
Active Clinical Trials



R01 resubmission- VOM clinical trial



Left Atrial Appendage Occlusion Device–Related Thrombus: Certainties and Uncertainties *
Valderrábano, M 2018, Journal of the American College of Cardiology, vol 71, no. 14, pp. 1537-1539. DOI: 10.1016/j.jacc.2018.01.077

Robotically Guided Left Ventricular Biopsy to Diagnose Cardiac Sarcoidosis: A Multidisciplinary Innovation Leading to First-in-Human Case
Bhimaraj, A, Trachtenberg, B & Valderrábano, M 2018, Circulation: Heart Failure, vol 11, no. 3, pp. e004627. DOI: 10.1161/CIRCHEARTFAILURE.117.004627

Multipolar electrode spline embolization
Hussain, MA & Valderrábano, M 2017, HeartRhythm Case Reports. DOI: 10.1016/j.hrcr.2017.10.014

Ligament of Marshall arrhythmogenesis and vein of Marshall ethanol: A problem with a solution
Valderrábano, M 2018, Heart Rhythm, vol 15, no. 1, pp. 25-27. DOI: 10.1016/j.hrthm.2017.09.013

Nanoparticles administered intrapericardially enhance payload myocardial distribution and retention
Segura-Ibarra, V, Cara, FE, Wu, S, Iruegas-Nunez, DA, Wang, S, Ferrari, M, Ziemys, A, Valderrabano, M & Blanco, E 2017, Journal of Controlled Release, vol 262, pp. 18-27. DOI: 10.1016/j.jconrel.2017.07.012

The Human Left Atrial Venous Circulation as a Vascular Route for Atrial Pharmacological Therapies.: Effects of Ethanol Infusion
Valderrábano, M, Morales, PF, Rodríguez-Mañero, M, Lloves, C, Schurmann, PA & Dave, AS 2017, JACC: Clinical Electrophysiology. DOI: 10.1016/j.jacep.2017.02.022

Ablation of Inappropriate Sinus Tachycardia. A Systematic Review of the Literature
Rodríguez-Mañero, M, Kreidieh, B, Al Rifai, M, Ibarra-Cortez, S, Schurmann, P, Álvarez, PA, Fernández-López, XA, García-Seara, J, Martínez-Sande, L, González-Juanatey, JR & Valderrábano, M 2016, JACC: Clinical Electrophysiology. DOI: 10.1016/j.jacep.2016.09.014

The Authors Reply:
Kitkungvan, D, Valderrabano, M & Shah, DJ 2016, JACC: Cardiovascular Imaging, vol 9, no. 12, pp. 1476. DOI: 10.1016/j.jcmg.2016.10.002

TCT-26 Long-Term Event Rates for Left Atrial Appendage Closure with WATCHMAN: PROTECT AF 5 Year and PREVAIL 3 Year Follow-up
Reddy, V, Price, M, Valderrabano, M, Sanchez, J, Doshi, S, Gordon, N & Holmes, D 2016, Journal of the American College of Cardiology, vol 68, no. 18S, pp. B11. DOI: 10.1016/j.jacc.2016.09.046

TCT-615 Do patients with CKD benefit from Left Atrial Appendage Closure (LAAC) with WATCHMAN?: Insights from PROTECT AF
Valderrabano, M, Price, M, Reddy, V, Buchbinder, M, Holmes, D, Sievert, H, Turi, Z, Gordon, N, Mullin, C, Sick, P & Best, P 2016, Journal of the American College of Cardiology, vol 68, no. 18S, pp. B251. DOI: 10.1016/j.jacc.2016.09.756

Position-Dependent Ventricular Tachycardia Related to Peripherally Inserted Central Venous Catheter
Alvarez, P, Schurmann, P, Smith, M, Valderrábano, M & Lin, CH 2016, Houston Methodist DeBakey Cardiovascular Journal, vol 12, no. 3, pp. 177-178. DOI: 10.14797/mdcj-12-3-177

Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics
Shivkumar, K, Ajijola, OA, Anand, I, Armour, JA, Chen, PS, Esler, M, De Ferrari, GM, Fishbein, MC, Goldberger, JJ, Harper, RM, Joyner, MJ, Khalsa, SS, Kumar, R, Lane, R, Mahajan, A, Po, S, Schwartz, PJ, Somers, VK, Valderrabano, M, Vaseghi, M & Zipes, DP 2016, Journal of Physiology, vol 594, no. 14, pp. 3911-3954. DOI: 10.1113/JP271870

Retrograde coronary venous ethanol infusion for ablation of refractory ventricular tachycardia
Kreidieh, B, Rodríguez-Mañero, M, Schurmann, PA, Ibarra-Cortez, SH, Dave, AS & Valderrábano, M 2016, Circulation: Arrhythmia and Electrophysiology, vol 9, no. 7. DOI: 10.1161/CIRCEP.116.004352

Clinical Implications of Leaks Following Left Atrial Appendage Ligation with the LARIAT Device
Gianni, C, Di Biase, L, Trivedi, C, Mohanty, S, Gökoglan, Y, Günes, MF, Bai, R, Al-Ahmad, A, Burkhardt, JD, Horton, RP, Krumerman, AK, Palma, EC, Valderrábano, M, Gibson, D, Price, MJ & Natale, A 2016, JACC: Cardiovascular Interventions, vol 9, no. 10, pp. 1051-1057. DOI: 10.1016/j.jcin.2016.01.038

Strategies for phrenic nerve preservation during ablation of inappropriate sinus tachycardia
Ibarra-Cortez, SH, Rodríguez-Mañero, M, Kreidieh, B, Schurmann, P, Dave, AS & Valderrábano, M 2016, Heart Rhythm. DOI: 10.1016/j.hrthm.2016.01.021

Monomorphic ventricular tachycardia in patients with Brugada syndrome: A multicenter retrospective study
Rodríguez-Mañero, M, Sacher, F, Asmundis, CD, Maury, P, Lambiase, PD, Sarkozy, A, Probst, V, Gandjbakhch, E, Castro-Hevia, J, Saenen, J, Fukushima Kusano, K, Rollin, A, Arbelo, E, Valderrábano, M, Arias, MA, Mosquera-Pérez, I, Schilling, R, Chierchia, GB, García-Bolao, I, García-Seara, J, Hernandez-Ojeda, J, Kamakura, T, Martínez-Sande, L, González-Juanatey, JR, Haïssaguerre, M, Brugada, J & Brugada, P 2016, Heart Rhythm, vol 13, no. 3, pp. 669-682. DOI: 10.1016/j.hrthm.2015.10.038

Vagal stimulation to suppress alternans: Are we saving lives or simply masking surrogate markers?
Rodríguez-Mañero, M & Valderrábano, M 2016, Heart Rhythm, vol 13, no. 3, pp. 729-730. DOI: 10.1016/j.hrthm.2015.11.038

The cost effectiveness of LAA exclusion
Kreidieh, B, Rodríguez-Mañero, M, Ibarra-Cortez, SH, Schurmann, P & Valderrábano, M 2016, Journal of Atrial Fibrillation, vol 8, no. 5, pp. 37-42.

Ligament and vein of Marshall: A therapeutic opportunity in atrial fibrillation
Rodríguez-Mañero, M, Schurmann, P & Valderrábano, M 2016, Heart Rhythm, vol 13, no. 2, pp. 593-601. DOI: 10.1016/j.hrthm.2015.10.018

Bleeding Outcomes after Left Atrial Appendage Closure Compared with Long-Term Warfarin A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience
Price, MJ, Reddy, VY, Valderrábano, M, Halperin, JL, Gibson, DN, Gordon, N, Huber, KC & Holmes, DR 2015, JACC: Cardiovascular Interventions, vol 8, no. 15, pp. 1925-1932. DOI: 10.1016/j.jcin.2015.08.035